There are many multiple sclerosis medications with different primary applications. Working with doctors can help determine which medication will be most suitable and which a person should avoid.
Some medications can cause severe side effects, so it is essential to weigh pros and cons of potential treatment with a medical professional before taking them.
People may wish to consider both the significant benefits and adverse effects caused by newer medications, such as fingolimod (Gilenya), natalizumab (Tysabri), and alemtuzumab (Lemtrada) for treating their Multiple Sclerosis.
However, Medical News Today is not advising people to always avoid these drugs. A person should discuss medications with a doctor to examine the benefits versus risk ratio.
This article discusses the safety profile of various multiple sclerosis medications. It also examines how to manage symptoms and relapses.
This ratio may vary with the severity of multiple sclerosis (MS). It also may depend on whether someone is pregnant or what co-occurring conditions they have, such as heart problems. Other factors to consider are an individual’s response to a medication, as well as their preference regarding the level of risks.
The below medications may have life threatening risks:
Fingolimod (Gilenya) has possible serious effects that include:
- infections that can cause death
- progressive multifocal leukoencephalopathy, a rare brain infection that is usually fatal or results in severe disability
- posterior reversible encephalopathy syndrome, a rare condition involving narrowing and swelling of blood vessels in the brain
- macular edema, swelling in a part of the eye that may cause blurred vision
- shortness of breath
- increased blood pressure
- types of skin cancer
- severe worsening of MS after stopping treatment
- relapses of tumefactive multiple sclerosis, a rare type that results in tumor-like growths in the brain
Natalizumab (Tysabri) has possible serious side effects that include:
- progressive multifocal leukoencephalopathy
- herpes infection that may raise the likelihood of an infection of the brain or an infection of the covering of the spinal cord and brain, called the meninges
- liver damage
- weakened immunity and increased risk of infections
- low blood platelets, the component of the blood that helps clots form and prevents excessive bleeding
Alemtuzumab (Lemtrada) has possible serious side effects that include:
- serious and sometimes fatal kidney and autoimmune problems, which are conditions where the body attacks healthy tissues and cells
- serious and life threatening stroke
- serious and life threatening infusion reactions, which are hypersensitivity responses to the administration of a drug into the bloodstream
- an increased likelihood of certain cancers
- overactivity of the immune system, which can be fatal
- inflammation of the liver
- reduction in the number of some types of blood cells
- progressive multifocal leukoencephalopathy
- a higher risk of serious infections
- bleeding conditions
- thyroid conditions
- blood clotting problems
The above three medications are the most effective. However, they also have the most serious side effects, so you may want to discuss with your doctor which drug is the best option for treating your MS.
Interferon-β preparations, such as Avonex and glatiramer acetate (Copaxone), are only moderately effective and may cause less serious side effect such as injection site reactions (redness, pain, swelling), flushing, shortness of breath, rash, and chest pain.
However, they rarely have life threatening side effects,
Interferon-β -1a (Avonex) has possible serious side effects that include:
- suicidal thoughts, depression, and hallucinations
- heart problems, including heart failure
- liver problems, including liver failure and death
- blood problems
- autoimmune conditions
- injury to red blood cells, small blood vessels, and platelets that can sometimes lead to death
- injection site reactions, including severe skin damage or a skin infection
Glatiramer acetate (Copaxone) has possible serious side effects that involve liver problems, including liver failure. It may also damage the fatty tissue under the skin and, rarely, cause the death of skin tissue.
Together with multiple sclerosis medications, many symptoms respond well to lifestyle changes, such as increased exercise, which can improve the following:
- cognition, or the ability to think
- muscle stiffness
- bowel function
Additionally, below are some management approaches for specific symptoms:
- Walking problems: Strategies involve fall prevention training and the use of mobility aids, such as a walker.
- Bladder control problems: Strategies entail using absorbent pads, limiting caffeine intake, and doing pelvic floor exercises.
- Bowel dysfunction: Strategies include eating a high fiber diet, drinking an adequate amount of fluids, and undergoing bowel training.
- Cognitive dysfunction: Strategies involve compensatory methods, which are tools and procedures that aim to improve cognitive function through substitutions.
- Slurred speech: Strategies entail speech and language therapy, which may include using alternative communication devices.
- Swallowing difficulties: Strategies include diet modification and exercise programs to strengthen the muscles that ease swallowing.
- Tiredness: This includes assistive devices and techniques for energy conservation and work simplification.
- Mood changes: Antidepressants are a common strategy.
- Sensory symptoms: Strategies to address tingling or pain include topical application of capsaicin acid cream or meditation.
- Sexual dysfunction: In addition to medications, strategies involve prosthetic devices for males and lubrication and increased stimulation for females.
- Spasticity: Strategies entail balance training and stretching.
- Tremors: Strategies include coordination and balance exercises, as well as special writing and eating utensils.
- Vertigo: Strategies to address the sensation of whirling or spinning involve vestibular rehabilitation, which aims to improve inner ear functions.
- Visual impairment: Adaptive equipment or environmental modifications can help with functional difficulties due to vision loss.
Doctors define relapse as any new or sudden worsening neurological symptom that is due to multiple sclerosis. It must last longer than 24 hours and appear at least 30 days following the onset of the previous relapse.
Aside from medications, rehabilitation can help people optimize or regain function after a relapse. This includes:
- physical therapy, which can provide an exercise program to increase strength and gait
- occupational therapy for training in energy conservation and the use of adaptive equipment
- speech and language pathology to help with speech and swallowing problems
- nursing to help with bowel and bladder management
Multiple sclerosis medications have different safety profiles that depend on various factors, including the severity of the condition and any co-occurring conditions, such as heart trouble.
However, if a person’s MS is mild, they should discuss both the risks and benefits of newer drugs such as fingolimod (Gilenya), natalizumab (Tysabri), and alemtuzumab (Lemtrada).
There are many ways to manage symptoms. These include measures such as avoiding caffeine to alleviate bladder problems and using energy conservation techniques to reduce tiredness.
Rehabilitation programs can help manage relapses.